298 related articles for article (PubMed ID: 19294363)
1. Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.
Delghingaro-Augusto V; Nolan CJ; Gupta D; Jetton TL; Latour MG; Peshavaria M; Madiraju SR; Joly E; Peyot ML; Prentki M; Leahy J
Diabetologia; 2009 Jun; 52(6):1122-32. PubMed ID: 19294363
[TBL] [Abstract][Full Text] [Related]
2. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
3. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Zhou YP; Cockburn BN; Pugh W; Polonsky KS
Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
[TBL] [Abstract][Full Text] [Related]
4. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
5. beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats.
Liu YQ; Jetton TL; Leahy JL
J Biol Chem; 2002 Oct; 277(42):39163-8. PubMed ID: 12147706
[TBL] [Abstract][Full Text] [Related]
6. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass.
Peyot ML; Pepin E; Lamontagne J; Latour MG; Zarrouki B; Lussier R; Pineda M; Jetton TL; Madiraju SR; Joly E; Prentki M
Diabetes; 2010 Sep; 59(9):2178-87. PubMed ID: 20547980
[TBL] [Abstract][Full Text] [Related]
8. Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes.
Cockburn BN; Ostrega DM; Sturis J; Kubstrup C; Polonsky KS; Bell GI
Diabetes; 1997 Sep; 46(9):1434-9. PubMed ID: 9287043
[TBL] [Abstract][Full Text] [Related]
9. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
[TBL] [Abstract][Full Text] [Related]
10. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase.
Jetton TL; Lausier J; LaRock K; Trotman WE; Larmie B; Habibovic A; Peshavaria M; Leahy JL
Diabetes; 2005 Aug; 54(8):2294-304. PubMed ID: 16046294
[TBL] [Abstract][Full Text] [Related]
12. Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass.
Fontés G; Zarrouki B; Hagman DK; Latour MG; Semache M; Roskens V; Moore PC; Prentki M; Rhodes CJ; Jetton TL; Poitout V
Diabetologia; 2010 Nov; 53(11):2369-79. PubMed ID: 20628728
[TBL] [Abstract][Full Text] [Related]
13. Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats.
Ogino T; Zhu M; Murakami T; Kuwajima M; Shima K
J Med Invest; 1998 Aug; 45(1-4):103-10. PubMed ID: 9864970
[TBL] [Abstract][Full Text] [Related]
14. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
[TBL] [Abstract][Full Text] [Related]
15. The Role of Fatty Acid Signaling in Islet Beta-Cell Adaptation to Normal Pregnancy.
Kim JH; Delghingaro-Augusto V; Chan JY; Laybutt DR; Proietto J; Nolan CJ
Front Endocrinol (Lausanne); 2021; 12():799081. PubMed ID: 35069446
[TBL] [Abstract][Full Text] [Related]
16. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
Unger RH
Diabetes; 1995 Aug; 44(8):863-70. PubMed ID: 7621989
[TBL] [Abstract][Full Text] [Related]
17. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.
Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP
Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425
[TBL] [Abstract][Full Text] [Related]
18. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets.
Getty-Kaushik L; Richard AM; Deeney JT; Krawczyk S; Shirihai O; Corkey BE
Obesity (Silver Spring); 2009 Oct; 17(10):1856-60. PubMed ID: 19644453
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa YA; Hosokawa H; Chen C; Leahy JL
J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
[TBL] [Abstract][Full Text] [Related]
20. Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.
Prentki M; Madiraju SR
Mol Cell Endocrinol; 2012 Apr; 353(1-2):88-100. PubMed ID: 22108437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
